HA
Haw Par Corporation Limited
HAWPF · OTC
$10.80 +0.00% (+$0.00)
Market Cap $3.39B
P/E Ratio 12.78x
Div. Yield 2.63%
ROE 6.15%
Bulios Fair Price
$12.73
17.9% upside
Current Price
$10.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HAWPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
63 /100
Fair P/B 0.79x
P/S 14.75x
P/E 12.78x
Growth
81 /100
Growing Book val. growth 6.51%
FCF growth 133.20%
EPS growth 21.44%
Profitability
100 /100
Strong FCF margin 117.05%
Op. margin 29.17%
Gross margin 55.99%
Quality
18 /100
Poor Asset turnover 0.05x
ROA 6.01%
ROIC 1.46%
Debt
100 /100
Low Net debt/EBITDA -10.17x
Int. coverage 44.05x
Debt/Equity 0.01x
Stability
60 /100
Moderate Profitable years 6
EPS volatility 21.25%
Beta 0.16x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HAWPF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
Employees
595
Headquarters
Singapore